1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INNATE PHARMA - ADR
Innate Pharma - ADR
XNAS: IPHA
1.41 0.01 (0.71%)
10,599.4
XNAS Volume

XNAS 28 Apr, 2026 3:13 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Innate Pharma (ADR) is on 01 May 2026 for the purpose of Innate Pharma SA Annual Report for 2025 See details


Insider Trading disclosures for Innate Pharma (ADR)

There were no Insider Trade disclosures made for Innate Pharma (ADR)

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures